Sunny Isles Seaside, Florida, Miami, RK Facilities shopping center, enterprise signal, CVS Pharmacy retail retailer, drugstore chain prescription medication. (Picture by: Jeffrey Greenberg/Common Photographs Group through Getty Photographs)
Jeff Greenberg | Common Photographs Group | Getty Photographs
The U.S. Federal Reserve reduce key rates of interest by 25 foundation factors, decreasing borrowing prices for the third time in 2025. Given the decrease rate of interest backdrop (which reduces the attraction of fixed-income investments) and a risky inventory market, some buyers would possibly wish to think about including dividend shares to their portfolios to make sure secure earnings and improve general returns.
The inventory picks of high Wall Avenue analysts might help buyers choose enticing dividend-paying corporations.
Listed here are three dividend-paying shares, highlighted by Wall Avenue’s high professionals, as tracked by TipRanks, a platform that ranks analysts based mostly on their previous efficiency.
Devon Power
This week’s first dividend decide is Devon Power (DVN), an unbiased oil and pure fuel exploration and manufacturing (E&P) firm. Within the third quarter of 2025, Devon returned $401 million to shareholders by share repurchases and dividends. The corporate’s mounted quarterly dividend of $0.24 per share (annualized dividend of $0.96 per share) signifies a yield of two.5%.
Lately, JP Morgan analyst Arun Jayaram upgraded Devon Power inventory to purchase from maintain, although he lowered the value goal to $44 from $49. TipRanks’ AI Analyst has an “outperform” score on DVN inventory with a worth goal of $43.
Jayaram defined that his score improve was based mostly on DVN’s compelling valuation in comparison with its friends, supported by free money stream positive factors from the corporate’s $1 billion enterprise optimization plan. The 5 star analyst famous that Devon achieved about 60% of its $1 billion objective in a bit of over half a yr following the plan’s formal rollout.
The analyst famous that Devon’s Delaware Basin properly productiveness was adversely impacted by the corporate’s give attention to finishing the next proportion of Wolfcamp B wells. That mentioned, Jayaram expects properly productiveness to be secure in 2026 and 2027 attributable to a “steadier mixture of secondary zones” in comparison with 2025.
General, Jayaram is bullish on Devon, on condition that it has a top-quality acreage place in crucial components of the Delaware Basin, Bakken, and Eagle Ford shale areas. Furthermore, the corporate has the choice to increase within the STACK and Powder River Basins.
“We imagine DVN’s core franchise belongings have the potential to supply a big stock of lower-risk, excessive rate-of-return growth drilling alternatives which can be crucial given the depleting nature of an E&P’s asset base,” mentioned Jayaram.
Jayaram ranks No. 655 amongst greater than 10,100 analysts tracked by TipRanks. His rankings have been worthwhile 59% of the time, delivering a median return of 10.3%. See Devon Power Statistics on TipRanks.
EOG Assets
The subsequent dividend-paying inventory is EOG Assets (EOG), a crude oil and pure fuel exploration and manufacturing firm with reserves within the U.S. and Trinidad. Within the third quarter of 2025, EOG paid $545 million in common dividends and repurchased shares price $440 million. Final month, EOG introduced a quarterly dividend of $1.02 per share, payable on January 30, 2026. At an annualized dividend of $4.08, EOG’s yield stands at 3.7%.
Siebert Williams Shank analyst Gabriele Sorbara reaffirmed a purchase score on EOG inventory with a worth goal of $150. The inventory additionally scores an “outperform” score from TipRanks’ AI Analyst, with a worth goal of $127.
Sorbara views EOG as a “premier” large-cap firm with the power to navigate by commodity cycles, supported by its strong stability sheet and powerful stock. The analyst additionally famous the corporate’s large free money flow-generating capabilities.
Notably, Sorbara highlighted EOG’s dedication to return no less than 70% of its free money stream to shareholders yearly by dividends and share buybacks. In actual fact, the vitality firm has the flexibleness to return 100% of free money stream based mostly on its stability sheet energy.
The 5-star analyst additionally famous EOG’s efforts to leverage superior expertise to seize additional alternatives within the Delaware Basin, with the corporate now figuring out greater than 9 completely different growth targets. Amongst different positives, Sorbara additionally talked about that EOG is monitoring forward of its goal for the primary yr with regard to the $150 million synergies from its Encino acquisition. Extra financial savings are anticipated from elements like improved infrastructure, manufacturing effectivity, and advertising and marketing offers by EOG’s midstream community.
Sorbara ranks No. 225 amongst greater than 10,100 analysts tracked by TipRanks. His rankings have been profitable 61% of the time, delivering a median return of 18.4%. See EOG Assets Possession Construction on TipRanks.
CVS Well being
Lastly, let’s take a look at pharmacy chain CVS Well being (CVS). The corporate’s turnaround efforts are serving to it drive improved efficiency in a difficult enterprise backdrop. At its Investor Day occasion on December 9, CVS Well being supplied constructive updates and said that it expects to attain a mid-teens adjusted earnings per share (EPS) compound annual progress price (CAGR) by 2028. At a quarterly dividend of $0.665 per share (annualized dividend of $2.66 per share), CVS inventory gives a yield of three.4%.
Following Investor Day, Mizuho analyst Ann Hynes reiterated a Purchase score on CVS inventory and raised her worth goal to $95 from $88. “CVS is our high decide in our protection universe,” mentioned the 5-star analyst, and cited structural enchancment in retail earnings forecast as the explanation for her revised worth goal. Apparently, TipRanks’ AI Analyst has a “impartial” score on CVS with a worth goal of $81.
Hynes famous that CVS’ mid-teens adjusted EPS CAGR goal doesn’t take note of any further share buybacks, which she expects to happen as soon as the corporate achieves its leverage targets, presumably by the top of subsequent yr.
The analyst additionally highlighted the corporate’s efforts to enhance margins of the Healthcare Advantages (HCB) section, which has been below strain attributable to a continued rise within the medical loss ratio (MLR). This ratio is anticipated to say no by about 50 foundation factors in 2026 attributable to higher pricing, decreased advantages below Medicare Benefit (MA) plans, and the corporate’s determination to exit the Well being Insurance coverage Alternate (HIX) enterprise.
Hynes additionally famous the advance in CVS’ Pharmacy and Shopper Wellness (PCW) section outlook, with the corporate now anticipating flat adjusted working earnings progress in comparison with the earlier steerage of a mid-single-digit decline. This enchancment is pushed by market share positive factors, a greater reimbursement backdrop, and value financial savings.
Hynes ranks No. 733 amongst greater than 10,100 analysts tracked by TipRanks. Her rankings have been profitable 60% of the time, delivering a median return of 8.5%. See CVS Well being Choices Exercise on TipRanks.
